Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

46.79
Delayed Data
As of Jul 29
 +0.07 / +0.15%
Today’s Change
37.59
Today|||52-Week Range
58.05
-13.46%
Year-to-Date
Mylan's Weakness Shouldn't Last, So Buy Now
Jul 29 / TheStreet.com - Paid Partner Content
Stock Market News for July 21, 2016
Jul 21 / Zacks.com - Paid Partner Content
Zacks.com featured highlights: Korea Electric Power, Third Point Reinsurance, Mylan N...
Jul 28 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Manulife Financial, Mylan, Huntsman, Air Lease and...
Jul 18 / Zacks.com - Paid Partner Content
4 Buy-Rated Stocks with High Earnings Yield
Jul 27 / Zacks.com - Paid Partner Content
Biosimilars set topple two of the world's biggest drug franchises
Jul 14 / FT.com - Paid Partner Content
Where Is the Insider Buying?
Jul 25 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close46.72
Today’s open46.70
Day’s range46.11 - 46.94
Volume2,658,918
Average volume (3 months)4,699,524
Market cap$23.9B
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-27.35%
Earnings growth (this year)+14.82%
Earnings growth (next 5 years)+11.41%
Revenue growth (last year)+21.91%
P/E ratio20.2
Price/Sales2.84
Price/Book2.36

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...+0.79+0.82%
ZTSZoetis Inc+0.41+0.82%
ALXNAlexion Pharmaceutic...-1.80-1.38%
INCYIncyte Corp+2.09+2.37%
Data as of 4:14pm ET, 07/29/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)$1.13
Annual revenue (last year)$9.5B
Annual profit (last year)$847.6M
Net profit margin8.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts

Partner Offers

Search for Jobs